WHO Updates Non-severe COVID-19 Treatment Guidance
The World Health Organization updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19.
Tag: remdesivir Veklury
All
Latest
All
LatestFDA Warns Against Remdesivir Compounds
The FDA is alerting healthcare professionals and compounders of potential risks associated with compounding remdesivir drug products.
All
Latest
Remdesivir Study Finally Published – An Expert in Critical Care Medicine Gives us His Verdict
The results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have been published.
Remdesivir Granted FDA Emergency Use to treat COVID-19
The US FDA issued an emergency use authorization for remdesivir, which recently demonstrated it could shorten time to recovery for some COVID-19 patients.
Read More
Remdesivir Has “Clear-cut” Benefits for COVID-19
The investigational antiviral remdesivir “has a clear-cut, positive effect in diminishing the time to recovery” for patients infected with COVID-19, NIAID director Anthony Fauci says.
Read More
Remdesivir Prevents COVID-19 Progression in Monkeys
Early treatment with the antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2.
Read More
Unclear Results for Gilead’s Remdesivir for Severe Covid-19
The first clinical results for remdesivir’s effectiveness on severe COVID-19 demonstrated clinical improvements but remain unclear because no control group was included in the study.
Read More